1. Home
  2. PRME vs CANG Comparison

PRME vs CANG Comparison

Compare PRME & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • CANG
  • Stock Information
  • Founded
  • PRME 2019
  • CANG 2010
  • Country
  • PRME United States
  • CANG China
  • Employees
  • PRME N/A
  • CANG N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • CANG Computer Software: Prepackaged Software
  • Sector
  • PRME Health Care
  • CANG Technology
  • Exchange
  • PRME Nasdaq
  • CANG Nasdaq
  • Market Cap
  • PRME 624.0M
  • CANG 509.9M
  • IPO Year
  • PRME 2022
  • CANG 2018
  • Fundamental
  • Price
  • PRME $3.72
  • CANG $5.07
  • Analyst Decision
  • PRME Buy
  • CANG Strong Buy
  • Analyst Count
  • PRME 6
  • CANG 1
  • Target Price
  • PRME $8.88
  • CANG $8.00
  • AVG Volume (30 Days)
  • PRME 3.0M
  • CANG 493.4K
  • Earning Date
  • PRME 08-07-2025
  • CANG 11-03-2025
  • Dividend Yield
  • PRME N/A
  • CANG N/A
  • EPS Growth
  • PRME N/A
  • CANG N/A
  • EPS
  • PRME N/A
  • CANG N/A
  • Revenue
  • PRME $4,961,000.00
  • CANG $398,195,540.00
  • Revenue This Year
  • PRME $179.58
  • CANG $469.55
  • Revenue Next Year
  • PRME N/A
  • CANG $18.83
  • P/E Ratio
  • PRME N/A
  • CANG N/A
  • Revenue Growth
  • PRME 739.42
  • CANG 380.74
  • 52 Week Low
  • PRME $1.11
  • CANG $1.40
  • 52 Week High
  • PRME $5.17
  • CANG $9.66
  • Technical
  • Relative Strength Index (RSI)
  • PRME 54.32
  • CANG 56.26
  • Support Level
  • PRME $3.09
  • CANG $4.45
  • Resistance Level
  • PRME $3.49
  • CANG $4.98
  • Average True Range (ATR)
  • PRME 0.25
  • CANG 0.25
  • MACD
  • PRME 0.01
  • CANG 0.01
  • Stochastic Oscillator
  • PRME 95.49
  • CANG 86.11

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About CANG Cango Inc. each representing two (2)

Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in the bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and associated businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives the majority of its revenue from the bitcoin mining business.

Share on Social Networks: